Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome |
Lee, Jin Seo
(Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Ahn, Ji Yong (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Choi, Kee Don (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Song, Ho June (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Kim, Yong Hee (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) Lee, Gin Hyug (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Jung, Hwoon-Yong (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Ryu, Jin-Sook (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine) Kim, Sung-Bae (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Kim, Jong Hoon (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Park, Seung-Il (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) Cho, Kyung-Ja (Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine) Kim, Jin-Ho (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) |
1 | Lee JL, Park SI, Kim SB, et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004;15:947-954. DOI |
2 | Kim MK, Kim SB, Ahn JH, et al. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 2008;71:725-734. DOI |
3 | Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer 2008;122:155-164. DOI |
4 | van Westreenen HL, Westerterp M, Bossuyt PM, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 2004;22:3805-3812. DOI |
5 | Rosenbaum SJ, Stergar H, Antoch G, Veit P, Bockisch A, Kuhl H. Staging and follow-up of gastrointestinal tumors with PET/CT. Abdom Imaging 2006;31:25-35. DOI |
6 | Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007;25:4110-4117. DOI |
7 | Kim YJ, Kim JY, Do YR, Song HS, Kim OB. The efficacy of concurrent chemoradiotherapy for patients with inoperable esophageal cancer. Korean J Med 2007;72:37-43. |
8 | Lee GD, Kim YH, Kim JB, et al. Esophageal cancer associated with multiple primary cancers: surgical approaches and long-term survival. Ann Surg Oncol 2013;20:4260-4266. DOI |
9 | Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev 2008;17:1543-1549. DOI |
10 | Di Fiore F, Lecleire S, Pop D, et al. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007;102:2557-2563. DOI |
11 | Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005;46:752-757. |
12 | Matsubara T, Yamada K, Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:4336-4341. DOI |
13 | Park EK, Kwon JH, Lee JH, Lee SJ. Clinical study of multiple primary malignant tumor. Korean J Med 2005;69:410-418. |
14 | Choi JY, Lee KS, Kwon OJ, et al. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 2005;23:7654-7659. DOI |
15 | van Westreenen HL, Westerterp M, Jager PL, et al. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med 2005;46:1321-1325. |
16 | Warren S. Multiple primary malignant tumors. Am J Cancer 1932;16:1358-1414. |
17 | Greene F, Page D, Fleming I. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002. |
18 | Ajani J, D'Amico TA, Hayman JA, Meropol NJ, Minsky B; National Comprehensive Cancer Network. Esophageal cancer: clinical practice guidelines in oncology. J Natl Compr Canc Netw 2003;1:14-27. DOI |
19 | Kim JH, Choi EK, Kim SB, et al. Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer. Int J Radiat Oncol Biol Phys 2001;50:1-12. DOI |
20 | Koide N, Yazawa K, Koike S, Adachi W, Amano J. Oesophageal cancer associated with other primary cancers: a study of 31 patients. J Gastroenterol Hepatol 1997;12:690-694. DOI |
21 | Nagasawa S, Onda M, Sasajima K, Takubo K, Miyashita M. Multiple primary malignant neoplasms in patients with esophageal cancer. Dis Esophagus 2000;13:226-230. DOI |
22 | Poon RT, Law SY, Chu KM, Branicki FJ, Wong J. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 1998;65:1529-1534. DOI |
23 | Shibuya H, Wakita T, Nakagawa T, Fukuda H, Yasumoto M. The relation between an esophageal cancer and associated cancers in adjacent organs. Cancer 1995;76:101-105. DOI |